Product Recall Information
Zerbaxa (ceftolozane / tazobactam) 1 g/0.5 g powder for concentrate for solution for infusion
All batches of the above product were recalled to hospital level in Ireland on 18 December 2020 as a result of sterility assurance concerns.
Click here for the product recall letter issued by MSD to Hospital Pharmacies.
Click here for the product recall letter issued by MSD to affected medicines wholesalers.
Click here for the Dear Healthcare Professional letter issued by MSD to relevant Healthcare Professionals.